• Serum’s heat-stable rotavirus vaccine shines in phase 3 fiercepharma
    March 31, 2017
    Serum Institute of India’s rotavirus vaccine candidate showed better efficacy than Merck’s and GlaxoSmithKline’s approved vaccines in a late-stage trial, as well as tolerating much higher temperatures during storage, putting it in a strong position to not
PharmaSources Customer Service